Marcelo Capra

2.7k total citations
40 papers, 336 citations indexed

About

Marcelo Capra is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Marcelo Capra has authored 40 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Hematology, 16 papers in Oncology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Marcelo Capra's work include Multiple Myeloma Research and Treatments (22 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). Marcelo Capra is often cited by papers focused on Multiple Myeloma Research and Treatments (22 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Peptidase Inhibition and Analysis (7 papers). Marcelo Capra collaborates with scholars based in Brazil, United States and Greece. Marcelo Capra's co-authors include Meletios Α. Dimopoulos, Aírton Tetelbom Stein, Fernando Anschau, Sandrine Macé, Marie‐Laure Risse, Philippe Moreau, Joseph Mıkhael, Vânia Hungria, Michèle Cavo and Thierry Façon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marcelo Capra

36 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marcelo Capra Brazil 11 211 202 129 61 48 40 336
Sung‐Soo Yoon South Korea 9 152 0.7× 91 0.5× 120 0.9× 12 0.2× 58 1.2× 54 272
Dana Chiţu Netherlands 9 211 1.0× 70 0.3× 98 0.8× 38 0.6× 69 1.4× 19 328
L. Andres Sirulnik United States 10 96 0.5× 173 0.9× 106 0.8× 84 1.4× 33 0.7× 17 297
Donna Bucci United States 10 129 0.6× 97 0.5× 101 0.8× 28 0.5× 60 1.3× 18 319
Jason M. Melear United States 10 131 0.6× 203 1.0× 131 1.0× 30 0.5× 92 1.9× 56 354
Daniel Morillo Spain 9 152 0.7× 141 0.7× 98 0.8× 66 1.1× 32 0.7× 30 275
K. Elias Germany 10 386 1.8× 173 0.9× 312 2.4× 43 0.7× 38 0.8× 29 455
Marie‐Odile Petillon France 8 395 1.9× 325 1.6× 341 2.6× 95 1.6× 68 1.4× 11 555
Moira Lucesole Italy 8 219 1.0× 153 0.8× 34 0.3× 13 0.2× 85 1.8× 11 373
F. W. Cremer Germany 7 162 0.8× 140 0.7× 140 1.1× 32 0.5× 50 1.0× 11 295

Countries citing papers authored by Marcelo Capra

Since Specialization
Citations

This map shows the geographic impact of Marcelo Capra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcelo Capra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcelo Capra more than expected).

Fields of papers citing papers by Marcelo Capra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcelo Capra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcelo Capra. The network helps show where Marcelo Capra may publish in the future.

Co-authorship network of co-authors of Marcelo Capra

This figure shows the co-authorship network connecting the top 25 collaborators of Marcelo Capra. A scholar is included among the top collaborators of Marcelo Capra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marcelo Capra. Marcelo Capra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Richardson, Paul G., Aurore Perrot, Joseph Mıkhael, et al.. (2024). Allocation and validation of the second revision of the International Staging System in the ICARIA-MM and IKEMA studies. Blood Cancer Journal. 14(1). 209–209. 3 indexed citations
3.
Haverkos, Bradley M., Önder Alpdoğan, Robert A. Baiocchi, et al.. (2023). Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood Advances. 7(20). 6339–6350. 25 indexed citations
4.
Dimopoulos, Meletios Α., Vânia Hungria, Atanas Radinoff, et al.. (2023). S199: A PHASE 3, OPEN-LABEL, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF SINGLE AGENT BELANTAMAB MAFODOTIN VS POMALIDOMIDE PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (DREAMM-3). HemaSphere. 7(S3). e072005a–e072005a. 2 indexed citations
5.
Perrot, Aurore, Paul G. Richardson, Joseph Mıkhael, et al.. (2023). P968: ALLOCATION AND VALIDATION OF THE SECOND REVISION OF THE INTERNATIONAL STAGING SYSTEM IN THE ICARIA-MM AND IKEMA STUDIES. HemaSphere. 7(S3). e3398301–e3398301. 1 indexed citations
6.
7.
Martin, Thomas G., Marcelo Capra, Mohamad Mohty, et al.. (2022). Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Patients with Relapsed Multiple Myeloma: IKEMA Subgroup Analysis by Prior Transplantation. Transplantation and Cellular Therapy. 29(2). 134.e1–134.e7. 2 indexed citations
8.
Martin, Thomas G., Marcelo Capra, Mohamad Mohty, et al.. (2021). Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients Who Previously Underwent Transplantation: Ikema Subgroup Analysis. Transplantation and Cellular Therapy. 27(3). S65–S65. 2 indexed citations
9.
Capra, Marcelo, Thomas G. Martin, Philippe Moreau, et al.. (2021). Isatuximab plus carfilzomib and dexamethasone versus carfilzomib and dexamethasone in relapsed multiple myeloma patients with renal impairment: IKEMA subgroup analysis. Haematologica. 107(6). 1397–1409. 19 indexed citations
10.
Porcu, Pierluigi, Bradley M. Haverkos, Önder Alpdoğan, et al.. (2020). Oral Nanatinostat (Nstat) and Valganciclovir (VGCV) in Patients with Recurrent Epstein-Barr Virus (EBV)-Positive Lymphomas: Initial Phase 2 Results. Blood. 136(Supplement 1). 7–8. 2 indexed citations
11.
Maiolino, Ângelo, Philippe Moreau, Meletios Α. Dimopoulos, et al.. (2020). ISATUXIMAB PLUS CARFILZOMIB AND DEXAMETHASONE VS CARFILZOMIB AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (IKEMA): INTERIM ANALYSIS OF A PHASE 3, RANDOMIZED, OPEN-LABEL STUDY. Hematology Transfusion and Cell Therapy. 42. 262–263. 23 indexed citations
12.
Turgut, Mehmet, Philippe Moreau, Meletios Α. Dimopoulos, et al.. (2020). Isatuximab plus carfilzomib and dexamethasone vs. carfilzomib and dexamethasone in relapsed/refractory multiple myeloma (ikema): interim analysis of a phase 3, randomized, open-label study. Hematology Transfusion and Cell Therapy. 42. 51–52. 6 indexed citations
13.
Capra, Marcelo, Meral Beksaç, Paul G. Richardson, et al.. (2020). ISATUXIMAB PLUS POMALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AND SOFT-TISSUE PLASMACYTOMAS: ICARIA-MM SUBGROUP ANALYSIS. Hematology Transfusion and Cell Therapy. 42. 263–264. 4 indexed citations
14.
Anschau, Fernando, et al.. (2019). Efficacy of low-level laser for treatment of cancer oral mucositis: a systematic review and meta-analysis. Lasers in Medical Science. 34(6). 1053–1062. 44 indexed citations
15.
Xu, Xu Steven, Meletios Α. Dimopoulos, Pieter Sonneveld, et al.. (2018). Pharmacokinetics and Exposure–Response Analyses of Daratumumab in Combination Therapy Regimens for Patients with Multiple Myeloma. Advances in Therapy. 35(11). 1859–1872. 24 indexed citations
16.
17.
18.
Gelosa, Giorgio, Lucio Tremolizzo, R. Perego, et al.. (2009). Narrowing the window for ‘senile chorea’: A case with primary antiphospholipid syndrome. Journal of the Neurological Sciences. 284(1-2). 211–213. 5 indexed citations
19.
Zen, Paulo Ricardo Gazzola, Marcelo Capra, Lúcia M. R. Silla, et al.. (2008). ETV6/RUNX1 fusion lacking prognostic effect in pediatric patients with acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 188(2). 112–117. 2 indexed citations
20.
Capra, Marcelo, et al.. (1996). Síndrome de Down: caracteristicas clínicas, perfil epidemiológico e citogenético em recém-nascidos no Hospital de Clínicas de Porto Alegre. Lume (Universidade Federal do Rio Grande do Sul). 8–13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sung‐Soo Yoon Breakdown of academic impact, for papers by Dana Chiţu Breakdown of academic impact, for papers by L. Andres Sirulnik Breakdown of academic impact, for papers by Donna Bucci Breakdown of academic impact, for papers by Jason M. Melear Breakdown of academic impact, for papers by Daniel Morillo Breakdown of academic impact, for papers by K. Elias Breakdown of academic impact, for papers by Marie‐Odile Petillon Breakdown of academic impact, for papers by Moira Lucesole Breakdown of academic impact, for papers by F. W. Cremer
Rankless by CCL
2026